Irritable Bowel Syndrome
Conditions
Interventions
Sponsors
Dongfang Hospital Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Patients with IBS-D diagnosed by western medicine; 2. Patients with IBS-SSS score > 75; 3. Patients with liver depression and spleen deficiency syndrome according to TCM syndrome differentiation; 4. Patients aged 18-65 years; 5. Subjects who signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with intestinal organic lesions (colonoscopy or colonoscopy report within 3 months); 2. Patients with contraindications of colonoscopy; 3. Patients with severe pathological changes of liver, brain, kidney and other major organs, and patients with mental disorders; 4. Patients with systemic diseases affecting gastrointestinal motility (such as hyperthyroidism, diabetes, chronic renal insufficiency, etc.); 5. Pregnant women and lactating women; 6. The patients who used other drugs to treat irritable bowel syndrome in the first week were screened; 7. Patients with allergic constitution, and those who are allergic to the known ingredients and any excipients of the drug in this study; 8. Patients with suspected or true history of alcohol or drug abuse; 9. Patients who participated in other clinical trials within three months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Abdominal pain intensity;Fecal traits; | — |
Secondary
| Measure | Time frame |
|---|---|
| Single symptom analysis;Two-class result measurement index;IBS Symptom Severity Scale;Effectiveness of TCM Syndrome;Quality of life score; | — |
Countries
China
Contacts
Public ContactXue Xiaoxuan
Dongfang Hospital of Beijing University of Chinese Medicine
Outcome results
None listed